Thus treatment of G-2 cells with the potent EMT-inducer TGFβ1 induced an enhanced plasticity of the tumor cells rather than a complete EMT, as evidenced by the absence of changes in the levels of phenotypic markers. The gene discussed is TGFB1; the disease is neoplasm.